If you're someone who prefers to wash up by hand rather than using a dishwasher, you probably reach for the trusty sponge or scourer to scrub away food remnants from your dishes. However ...

In a bold and unanticipated move, Swatch and Blancpain have unveiled the rearmost addition to their Bioceramic Scuba Fifty Fathoms collection the "PINK OCEAN" watch.

Doused in various shades of pink, the Bioceramic Scuba Fifty Fathoms comes with a ... Its hands, indices along the 60 minutes diving scale are all coated in Grade A Super-LumiNova®, offering ...

Now, a new variant of the latter has been unveiled – and it just might be my dream dive watch. It's called the Pink Ocean and it's a watch which truly lives up to its name. The Bioceramic case ...

Cameras have become almost essential dive gear, and in the world of 4K social media streaming, the action camera is king. Here are some of the best action cameras for scuba diving currently available ...

Meet the bright and bold Blancpain × Swatch Scuba Fifty Fathoms Pink Ocean. The bold new Blancpain × Swatch Scuba Fifty Fathoms Pink Ocean employs a balanced blend of pink and magenta hues to create ...

I vividly recall my heart pounding as I stood in the famous Big Pink basement and watched him slowly descend the staircase and soak in a room he hadn’t occupied in nearly five decades.

On the first day, our dives were near Floreana Island at Champion, Enderby and Cormorant Point. The partnering dive operator, Scuba Iguana, required us to have open-water certifications and a minimum ...

Member of Parliament and writer Shashi Tharoor launched The Hindu’s latest product, Surf and Dive, a print product that gives readers in-depth coverage across a range of issues through long ...

Raja Ampat has to be top of the list for diving in Indonesia and, for most who’ve visited, the best scuba diving in the world. Ambon Bay has, in recent years, become one of the world’s top muck diving ...

Pharma dealmaking for drugs invented in China is putting pressure on U.S. biotechs to compete harder, according to investors and executives interviewed by BioPharma Dive.